## Abstract Zinc is an essential trace element that has stimulatory effects on bone formation. Recently, we developed zincโreleasing calcium phosphate ceramics in order to add the pharmacologic effect of zinc to calcium phosphate ceramics. In our previous study, we showed that the optimum zinc cont
Preparation, solubility, and cytocompatibility of zinc-releasing calcium phosphate ceramics
โ Scribed by Ito, Atsuo ;Ojima, Kenji ;Naito, Hiroshi ;Ichinose, Noboru ;Tateishi, Tetsuya
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 291 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0021-9304
No coin nor oath required. For personal study only.
โฆ Synopsis
Zinc is an essential trace element with stimulatory effects on bone formation. Therefore, zinc was doped into โค-tricalcium phosphate to develop zinc-releasing biomaterials to promote bone formation. The zinc-doped โค-tricalcium phosphate, โค-tricalcium phosphate, and hydroxyapatite powders were mixed at a (Ca+Zn)/P molar ratio of 1.60, followed by sintering into a dense body at 1100ยฐC for 1 h. The sintered body was a composite ceramic consisting of zinc-doped โค-tricalcium phosphate and hydroxyapatite phases. The composite ceramic contained zinc oxide when the zinc content was higher than 1.20 wt %. The composite ceramic released zinc under pseudophysiological conditions. However, the release of calcium and phosphate de-creased with an increase in zinc content in a range higher than 0.12 wt % owing to a decrease in solubility of the zincdoped โค-tricalcium phosphate phase. Proliferation of osteoblastic MC3T3-E1 cells was significantly increased on the composite ceramic with a zinc content from 0.6 to 1.20 wt %, compared with those without zinc. When the zinc content was higher than 1.20 wt %, release of zinc from the zinc oxide caused cytotoxicity. Therefore, the zinc content of the composite ceramic must be <1.20 wt %.
๐ SIMILAR VOLUMES
## Abstract Rat and human bone marrow cells (BMCs) were cultured on a composite ceramic of zincโcontaining ฮฒโtricalcium phosphate and hydroxyapatite (ZnTCP/HAP) with a (Ca+Zn)/P molar ratio of 1.60 and varying zinc contents. After a 2โweek culture of the BMCs in the presence of ฮฒโglycerophosphate a
Although hydroxyapatite (HAP) and tricalcium phosphate (TCP) are currently used as bone graft substitutes or coatings on metallic prostheses because of their excellent biocompatibility and osteoconductivity, they do not stimulate bone formation or inhibit bone resorption. Zinc, an essential trace el
## Abstract Two glass ceramics in the CaO๏ฃฟP~2~O~5~๏ฃฟMgO system with the incorporation of K~2~O or TiO~2~ oxides were prepared with the goal of using them as potential bone graft substitutes. The incorporation of TiO~2~ and K~2~O led to the preparation of specific crystalline phases in the structure
The purpose of this study was to evaluate the therapeutic efficacy of a new calcium phosphate (CaP)-based formulation in improving the bone mineral deficiency in ovariectomized (OVX) rats. The ions release experiments for CaP preparations (G2: 0.46% Mg, 5.78% Zn, and 2.5% F; G3:3.1% Mg, 0.03% Zn, an